Yes, Elon Musk will be able to test his chips on our brains if he fulfills a few conditions…

News Yes, Elon Musk will be able to test his chips on our brains if he fulfills a few conditions…

Published on 07/03/2023 at 12:40

Share :

Another promise that Elon Musk has a hard time keeping. He wanted to test his new neurochips on the human brain, but the Food and Drug Administration (FDA) abruptly halted his project, jeopardizing his ambitions. But if you meet a few conditions, it may be achievable.

Elon Musk makes promises before getting permissions…

No wonder Elon Musk again fails to deliver on his promises. As often, he does not bear direct responsibility, but announces things that are not entirely within his competence.

In a comprehensive investigation by our colleagues at Reuters, we find Elon Musk’s ambitions for Neuralink, as well as the FDA’s refusal to conduct human brain trials. Without this investigative work, we would never have known because, as a private company, Neuralink is not required to issue a disclaimer and the FDA cannot make it public.

We also discover that this was the fourth time since 2019 that Elon Musk planned in vain to test his chips on the human brain. However, the application was not submitted until early 2022.

Over the course of the year, the teams worked diligently to resolve and comply with the FDA’s requirements as quickly as possible. = What should I do if authorization went through earlier than expected? = An internal document provided by Neuralink staff says that a new request may come in. Again, Elon Musk is very positive about the outcome of this case. On the contrary, employees have trusted and are rather skeptical about the speed of fulfilling the requirements.

We cannot know what commitments the FDA has made to respect trade and research confidentiality. So we can read in the poll:

The Food and Drug Administration (FDA) says it has approved about two-thirds of all first-try human trial applications in the past three years. This total rose to 85% of all applications after re-examination.

But the problem is that the more applications you reject, the lower your chances of being approved. It was better to go back to the research stage and resolve all the issues raised by the FDA.

“Regulators are an obstacle to progress”

Elon Musk’s vision is clearly ultra-progressive, to the point of rejecting regulatory advice, even if he must always end up following it. This was seen when the Tesla Model S and Model 3 production speed had to be increased. And also during the development of the Starship rocket, which is not yet completed. Neuralink is just another business that Elon Musk can’t do due to regulations and constant approval requirements.

The problem is that by putting forward requests that they think should pass, regulators are making even higher demands. In the survey, Kip Ludwig, former program director of neural engineering at the National Institutes of Health, explains:

Neuralink doesn’t seem to have the mindset or experience to bring this to market anytime soon.

Especially since Elon Musk lives in a world where technology has taken over. To the point of announcing that his neurological chip could “record and replay memories” or even “restore full mobility to paralyzed patients.” And this is where she becomes a genius, because the entire value of the company is based on her speech and drop by drop shown results.

In an internal document, we find that permissions may have been given on March 7th. But pessimism is a must in teams. Describing this date more as a bet than anything else.

You should also be aware that Neuralink is a private company and not funded by the government. As a result, obtaining permission becomes much more difficult. Elon Musk justifies this choice by saying that he is not monitored or constantly has to deal with bureaucratic obstacles.

Wanting to hurry up, Elon Musk was known as a man who sees in the human brain a material instrument, not an organ. This is part of what the FDA seems to be concerned about.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker.